Cutler Group LLC / CA - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 156 filers reported holding CARDLYTICS INC in Q4 2019. The put-call ratio across all filers is 1.85 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2021$8,000
-33.3%
1000.0%0.00%
-100.0%
Q2 2021$12,000
+20.0%
1000.0%0.00%
Q1 2021$10,000
-96.0%
100
-94.7%
0.00%
-100.0%
Q4 2020$247,000
+105.8%
1,870
-52.9%
0.01%
+57.1%
Q3 2020$120,000
+29.0%
3,970
-56.8%
0.01%
+16.7%
Q2 2020$93,000
+22.4%
9,200
+104.4%
0.01%
+50.0%
Q1 2020$76,000
-25.5%
4,500
+66.7%
0.00%
-33.3%
Q4 2019$102,0002,7000.01%
Other shareholders
CARDLYTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders